Local cancer drug approved for first clinical trial in United States and New Zealand
30 August 2012
The US Food and Drug Administration (FDA) has granted approval for PR610, an anticancer “stealth” drug invented in New Zealand, to move forward to human clinical trials through its approval of an Investigational New Drug (IND) Application for the drug.
read more